Fennec Pharmaceuticals
FENC
39 hedge funds and large institutions have $88M invested in Fennec Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 24 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $89.2M → $88M (-$1.13M)
9.24% less ownership
Funds ownership: 55.69% → 46.46% (-9.2%)
25% less funds holding
Funds holding: 52 → 39 (-13)
54% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 24
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DG Capital Management
New York
|
+$3.93M |
| 2 |
Millennium Management
New York
|
+$2.7M |
| 3 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
+$807K |
| 4 |
E
Ergoteles
New York
|
+$616K |
| 5 |
SCM
Solas Capital Management
Darien,
Connecticut
|
+$453K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$7.14M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.46M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.03M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.35M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$1.23M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Invesco
Atlanta,
Georgia
| – | -$80K | -12,818 | Closed |
|
|
AIG
52
American International Group
New York
| – | -$79 | -12,685 | Closed |
|
53
VOYA Investment Management
Atlanta,
Georgia
| – | -$68K | -11,004 | Closed |
|
|
TRCT
54
Tower Research Capital (TRC)
New York
| – | -$31K | -5,075 | Closed |
|
55
Legal & General Group
London,
United Kingdom
| – | -$15K | -2,473 | Closed |
|
|
AIP
56
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$12K | -1,908 | Closed |
|
57
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$9 | -1,500 | Closed |
|
58
Citigroup
New York
| – | -$9K | -1,441 | Closed |
|
59
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$4K | -642 | Closed |
|
|
CG
60
Cutler Group
San Francisco,
California
| – | -$667 | -100 | -50% |
|
61
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$267 | +40 | +267% |
|
FENC Hedge Fund Activity: Q2 2021 in Review
39 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q2 2021, worth a combined $88M — down 1.3% from $89.2M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of FENC and 11 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 7 added.
The largest buyer was DG Capital Management, opening a new position worth an estimated $3.93M. The largest seller was BlackRock, cutting an estimated $7.14M.
- 39 institutional investors held Fennec Pharmaceuticals (FENC) as of Q2 2021, down from 52 in Q1 2021.
- Funds reported $88M of Fennec Pharmaceuticals stock for Q2 2021, down 1.3% quarter-over-quarter.
- 11 funds opened new Fennec Pharmaceuticals positions in Q2 2021 and 24 closed out, a net change of -13 holders.
- The largest Fennec Pharmaceuticals buyer in Q2 2021 was DG Capital Management, an estimated $3.93M added.
- The largest Fennec Pharmaceuticals seller in Q2 2021 was BlackRock, an estimated $7.14M sold.
Based on aggregated 13F filings for Q2 2021.